C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
12/2004
12/22/2004	CN1181098C Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan
12/16/2004	US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases
12/16/2004	US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/16/2004	CA2525975A1 Humanized antibodies that recognize beta amyloid peptide
12/15/2004	CN1555383A Novel peptide, novel adsorbent, adsorption unit and adsorption method
12/15/2004	CN1180260C Method for prepn. of water-soluble cross-linked conjugates
12/09/2004	WO2004106497A2 Imageable animal model of sars infection
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	WO2003066660A3 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILEDCOIL PEPTIDES
12/09/2004	US20040249130 Aptamer-toxin molecules and methods for using same
12/09/2004	US20040248782 Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design
12/09/2004	US20040248147 Biopolymer support for use in genomics, gene expression analysis, sequencing, DNA fingerprinting and mapping biological macromolecules
12/09/2004	US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering
12/09/2004	US20040247610 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations
12/09/2004	DE10322414A1 Immobilizing proteins on polymeric film substrates, useful in preparation of diagnostic and screening arrays, where the polymer has been modified with chromatographically active functional groups
12/09/2004	CA2527296A1 Imageable animal model of sars infection
12/08/2004	EP0833941A4 Polypeptides having a functional domain of interest and methods of identifying and using same
12/08/2004	CN1552737A Process for the preparation of resin-bound cyclic peptides
12/08/2004	CN1552728A Amine synthetic method
12/02/2004	WO2004103159A2 Methods for modulating endometrium
12/02/2004	WO2004036011A3 Biomolecular-based actuator
12/02/2004	WO2003072709A3 Variant tat proteins and methods for use thereof
12/02/2004	US20040242484 Specific polypeptides, useful as nematocides
12/02/2004	US20040241753 Device for producing polymer support materials in the form of porous polymer beads
12/02/2004	US20040241713 Composition for immobilization of biological macromolecules in hydrogels, a method for preparing a composition, a biochip, and a method for performing the PCR over biochip
12/02/2004	US20040241203 Porous matrix comprising cross-linked particles
12/02/2004	CA2524936A1 Compositions and methods for the preparation of human growth hormone glycosylation mutants
12/01/2004	EP0906448A4 Methods for the diagnosis and prognosis of cancer
12/01/2004	EP0895537B1 Iga1 protease fragment as carrier peptide
11/2004
11/30/2004	US6825031 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance
11/30/2004	US6824989 Screening/detection of disease for diagnosis/research; genetic engineering; electrophoresis
11/30/2004	US6824769 Compositions comprise alpha-interferon or a derivative thereof and an inosine monophosphate dehydrogenase inhibitor; hepatitis virus
11/25/2004	WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	US20040235713 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
11/25/2004	US20040235146 Receptor-ligand systems used for analysis; high throughput assay
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235050 Method for immobilization of polypeptides
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/24/2004	EP1137442B1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/18/2004	US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection
11/18/2004	CA2522345A1 Glycopegylation methods and proteins/peptides produced by the methods
11/17/2004	EP1476753A2 Functionalized compositions for improved immobilization
11/17/2004	EP1476182A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
11/16/2004	CA2059692C Pneumoccoccal polysaccharide conjugate vaccine
11/11/2004	WO2004097416A1 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for structure
11/11/2004	WO2004096831A2 Method of producing three-dimensional structures using motor proteins
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	CA2523402A1 Group 1 mite polypeptide variants
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2004	EP1137690B1 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions
11/10/2004	CN1544472A Branched polyethylene glycol-interferon and its making method and uses
11/10/2004	CN1544469A Anticoagulation raticide immunogen synthesis method
11/10/2004	CN1544468A Polyethylene glycol-interferon connected with amido bond and its making method and uses
11/10/2004	CN1544460A Protein A immunoadsorption medium regeneration and utilization process
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/04/2004	WO2004094597A2 Anthozoan fluorescent protein genes
11/04/2004	WO2004093823A2 Polyethelene glycol link glp-1 compounds
11/04/2004	WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	US20040219131 Interferon-alpha polypeptides and conjugates
11/04/2004	CA2523452A1 Cancer specific monoclonal antibodies
11/04/2004	CA2522364A1 Polymer-conjugated glycosylated neublastin
11/04/2004	CA2518336A1 Polyethelene glycol link glp-1 compounds
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	CN1543339A Porous matrix comprising cross-linked particles
11/03/2004	CN1174248C Graphitic nanotube for electrochemiluminescent detection , its composition ,detection agent and detection method thereof
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
10/2004
10/28/2004	WO2004092051A2 Organic polymeric material an method for the production thereof
10/28/2004	WO2004043386A3 Molecules preferentially associated with effector t cells and methods of their use
10/28/2004	WO2004005477A3 Protein microarrays on mirrored surfaces for performing proteomic analyses
10/28/2004	WO2004005319A3 Microarrays on mirrored substrates for performing proteomic analyses
10/28/2004	US20040214997 includes growth factors and extracellular matrix molecules flexibly tethered to a support medium; used to stimulate cell and tissue growth by enhancment of the biological response to the growth factor; liver cells
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214233 Protein microarray system
10/28/2004	US20040214228 Selecting glycoproteins with enhanced activities for use as diagnostic tools in disease diagnosis; glycomics; proteomics
10/28/2004	US20040214157 Chromatographic resins and methods for using same
10/28/2004	US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
10/28/2004	CA2521381A1 Method for preparation of site-specific protein conjugates
10/27/2004	EP1471355A1 Method of fixing biomolecule to carrier
10/27/2004	EP1437368A4 Composition for polymerising immobilisation of biological molecules and method for producing said composition
10/27/2004	EP1107793B1 Dextran-leptin conjugates, pharmaceutical compositions and related methods
10/26/2004	CA2177616C Preparation and use of immunoconjugates
10/21/2004	WO2004090542A1 Protein array and process for producing the same
10/21/2004	WO2004089977A1 Immobilized protein and process for producing the same
10/21/2004	WO2004089295A2 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
10/21/2004	WO2004010939A3 Methods of using non-human animal apoliprotein a-i protein
10/21/2004	US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds
10/21/2004	CA2521438A1 Prion protein binding materials and methods of use
10/20/2004	EP0886644B1 Long wavelength engineered fluorescent proteins
10/20/2004	EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18
10/20/2004	EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof

1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 107